California-based technologist and author Rajeev Nanda invites readers on a gripping intellectual and emotional journey with his latest book, “LOH,” which has achieved Amazon Bestseller status as #8 in ...

Biogen has won U.S. Food and Drug Administration breakthrough-therapy designation for its litifilimab drug candidate for the treatment of the chronic autoimmune disease cutaneous lupus erythematosus, ...

Three suspects have been arrested by the Serious Commercial Crimes Investigation (SCCI) unit in Johannesburg for their alleged involvement in a R4.4 million fraud and money laundering scheme linked to ...

Bezuclastinib combined with sunitinib shows promise for second-line GIST treatment, addressing resistance mutations after imatinib failure. The PEAK trial demonstrated significant clinical benefits, ...

Please provide your email address to receive an email when new articles are posted on . Ianalumab has received the FDA’s breakthrough therapy designation for Sjögren’s disease. Novartis plans to ...

Scientists at Stanford Medicine have discovered a treatment that can reverse cartilage loss in aging joints and even prevent arthritis after knee injuries. By blocking a protein linked to aging, the ...

Eli Lilly has won U.S. Food and Drug Administration breakthrough -therapy designation for its sofetabart mipitecan drug candidate for certain patients with ovarian cancer. Eli Lilly on Tuesday said ...

Regulatory submission for ianalumab in Sjögren disease is expected in early 2026, according to Novartis. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...

Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in development to treat certain ovarian cancer patients. The Indianapolis-based ...

Ianalumab, an investigational fully human monoclonal antibody drug being studied for its potential to treat various B cell-driven autoimmune diseases, received a Breakthrough Therapy designation for ...